Conagra Brands’ (NYSE: CAG) stock has dropped 9% over the past three months. The company has been facing a challenging environment, which led to a decline in sales and profits during its most recent quarter. The branded foods maker also lowered its guidance for the fiscal year as it anticipates headwinds from inflation. At the same time, Conagra’s brand-building investments have helped drive strong share gains.
Q2 performance
Conagra’s net sales dipped 0.4% year-over-year to $3.2 billion in the second quarter of 2025. Organic sales inched up 0.3%, reflecting a 0.4% growth in volume and a 0.1% negative impact from price/mix. Adjusted earnings per share fell 1.4% YoY to $0.70 in Q2. Adjusted gross margin decreased 52 basis points to 26.4%.
Navigating a dynamic consumer environment
As mentioned on the Q2 earnings call, consumers are facing economic pressures which has led to them prioritizing affordability and seeking maximum value on their purchases. Against this backdrop, many manufacturers are increasing their investments in advertising and promotions. Conagra’s strategy has been to invest in building its brands rather than rely on promotions to drive volume, and this move is paying off.
The company’s brand-building investments have helped drive strong market share performance and volume recovery. In Q2, 67% of CAG’s portfolio held or gained volume share. In the frozen and snacks categories, 87% of the portfolio held or gained volume share during the quarter.
Conagra saw strong frozen consumption in Q2, helped by volume share gains in single-serve meal brands, multi-serve meal brands, and Birds Eye Vegetables. The company is seeing good performance within its snacking portfolio, although high cocoa prices contributed to a decline in Swiss Miss hot chocolate. Excluding Swiss Miss, snacks volume rose 0.6% in Q2. CAG is also seeing encouraging volume trends in its staples category, along with strong performance in its chili business.
Outlook
Conagra expects its business to face pressures from higher than expected inflation and unfavorable foreign exchange rates in the second half of fiscal year 2025. The company plans on taking limited pricing actions late in the third quarter of 2025 to offset some inflation in cocoa and sugar, and it expects volumes and organic sales to improve in the second half of the year versus the first half.
Based on these factors, CAG updated its guidance for fiscal year 2025. It now expects organic sales growth for the full year to be near the midpoint of its guidance range of down 1.5% to flat versus FY2024.
Adjusted operating margin is now expected to be approx. 14.8% versus the previous range of 15.6-15.8%, as inflation is now expected to be closer to 4% versus the earlier expectation of around 3%. Adjusted gross margin is expected to contract by approx. 90 basis points versus last year. Adjusted EPS is now expected to range between $2.45-2.50 versus the prior outlook of $2.60-2.65.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note
UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next week. The company, a market leader in the nation's colossal
Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities
Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over the past few years, the toymaker has been focused on
AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%
AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding special items, was $0.04 per